yahoo_financeOriginal article
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy
Data ReadoutpositiveVivistim® Paired VNS™Positive
AI Analysis
Summary
Mobia Medical announced publication of two-year data from the VNS-REHAB trial showing durable and continued stroke recovery with Vivistim® Paired VNS™ therapy. The positive long-term efficacy data supports the continued clinical value of the therapy.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Two-year data from VNS-REHAB trial demonstrating durable and continued stroke recovery
Importance:6/10
Sentiment:
0.70
clinical datastrokeneuromodulationVNS therapypublication
Related Companies
Read the original article
Published by yahoo_finance on July 14, 2026 8:18 PM